ArticleJournal of managed care & specialty pharmacy2026
Real-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes.
Meredith M Hoog et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.